Previous close | 38.56 |
Open | 38.50 |
Bid | 37.29 x 900 |
Ask | 39.00 x 800 |
Day's range | 38.28 - 38.95 |
52-week range | 27.25 - 39.47 |
Volume | |
Avg. volume | 2,021,088 |
Market cap | 9.866B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 7.63 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.12 (2.99%) |
Ex-dividend date | 13 May 2022 |
1y target est | N/A |
JERSEY CITY, N.J., May 05, 2022--Organon (NYSE: OGN) (the "company"), today announced its results for the first quarter ended March 31, 2022.
JERSEY CITY, N.J., April 21, 2022--Organon To Report First Quarter Results and Host Conference Call on May 5, 2022
JERSEY CITY, N.J. & SAN DIEGO, March 31, 2022--Organon Enters into Global License Agreement to commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%)